2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

Circulation

Volumn 133, Issue 14, 2016, Pages e471-e505

  Page, Richard L ^e   Joglar, José A ^e   Caldwell, Mary A ^e   Calkins, Hugh ^a   Conti, Jamie B ^b,c   Deal, Barbara J ^b   Estes, N A Mark ^b   Field, Michael E ^b   Goldberger, Zachary D ^b   Hammill, Stephen C ^a   Indik, Julia H ^a   Lindsay, Bruce D ^a   Olshansky, Brian ^b   Russo, Andrea M ^c   Shen, Win Kuang ^d   Tracy, Cynthia M ^b   Al Khatib, Sana M ^b  

^a HRS Representative   (United States)

^b ACC AHA Representative   (United States)

^c ACC AHA Task Force on Performance Measures Liaison   (United States)

^d ACC AHA Task Force on Clinical Practice Guidelines Liaison   (United States)

^e NONE

Author keywords

accessory atrioventricular bundle; AHA Scientific Statements; anti arrhythmia agents; atrial flutter; catheter ablation; death, sudden; electric countershock; electrophysiologic techniques, cardiac; heart defects, congenital; sinus tachycardia; tachycardia, atrioventricular nodal reentry; tachycardia, ectopic atrial; tachycardia, ectopic junctional; tachycardia, reciprocating; tachycardia, supraventricular; Valsalva maneuver; Wolff Parkinson White syndrome

Indexed keywords

ADENOSINE; AMIODARONE; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DILTIAZEM; DOFETILIDE; FLECAINIDE; IBUTILIDE; IVABRADINE; METOPROLOL; PROCAINAMIDE; PROPAFENONE; PROPRANOLOL; SOTALOL; VERAPAMIL; CARDIOVASCULAR AGENT;

ADULT; AGED; ASYMPTOMATIC DISEASE; ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA; CARDIOVERSION; CATHETER ABLATION; CAVOTRICUSPID ISTHMUS EPENDENT ATRIAL FLUTTER; CHILD; CLINICAL DECISION MAKING; CLINICAL EVALUATION; CLINICAL FEATURE; CONGENITAL HEART DISEASE; COST EFFECTIVENESS ANALYSIS; CRYOABLATION; DEMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DRUG THERAPY; ELECTROCARDIOGRAPHY; FEMALE; FOCAL SUPRAVENTRICULAR TACHYCARDIA; GERIATRIC PATIENT; HEART ACCESSORY CONDUCTION PATHWAY; HEART ATRIUM FLUTTER; HEART ELECTROPHYSIOLOGY; HEART PREEXCITATION; HUMAN; INAPPROPRIATE SINUS TACHYCARDIA; MEDICAL SOCIETY; MULTIFOCAL SUPRAVENTRICULAR TACHYCARDIA; NON ISTHMUS DEPENDENT ATRIAL FLUTTER; PATIENT CARE; PATIENT DECISION MAKING; PEDIATRICS; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; PUBLIC HEALTH; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SINUS TACHYCARDIA; SUPRAVENTRICULAR TACHYCARDIA; SYSTEMATIC REVIEW (TOPIC); TREATMENT DURATION; ADOLESCENT; CARDIOVASCULAR SYSTEM EXAMINATION; CLASSIFICATION; COST BENEFIT ANALYSIS; DECISION MAKING; DISEASE MANAGEMENT; ECONOMICS; EVIDENCE BASED MEDICINE; MALE; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PRESCHOOL CHILD; TACHYCARDIA, SUPRAVENTRICULAR; YOUNG ADULT;

ADOLESCENT; ADULT; CARDIOVASCULAR AGENTS; CATHETER ABLATION; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; COST-BENEFIT ANALYSIS; DECISION MAKING; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; DISEASE MANAGEMENT; ELECTROCARDIOGRAPHY; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; QUALITY OF LIFE; TACHYCARDIA, SUPRAVENTRICULAR; YOUNG ADULT;

EID: 84944342446     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0000000000000310     Document Type: Review

References (397)

1. Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Institute of Medicine (US) Clinical Practice Guidelines We Can Trust 2011 Washington, DC National Academies Press
2. Committee on Standards for Systematic Reviews of Comparative Effectiveness Research, Institute of Medicine (US) Finding What Works in Health Care: Standards for Systematic Reviews 2011 Washington, DC National Academies Press
3. ACCF/AHA Task Force on Practice Guidelines Methodology Manual and Policies From the ACCF/AHA Task Force on Practice Guidelines. American College of Cardiology and American Heart Association 2010. Available at: http://assets.cardiosource.com/Methodology-Manual-for-ACC-AHA-Writing-Committees.pdf and http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/documents/downloadable/ucm-319826.pdf. Accessed January 23, 2015
4. Jacobs AK, Kushner FG, Ettinger SM, ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013 127 268 310
5. Jacobs AK, Anderson JL, Halperin JL, The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014 130 1208 17
6. Anderson JL, Heidenreich PA, Barnett PG, ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. Circulation 2014 129 2329 45
7. Halperin JL, Levine GN, Al-Khatib SM, Further evolution of the ACC/AHA clinical practice guideline recommendation classification system: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2016 133 1426 28
8. Arnett DK, Goodman RA, Halperin JL, AHA/ACC/HHS strategies to enhance application of clinical practice guidelines in patients with cardiovascular disease and comorbid conditions: from the American Heart Association, American College of Cardiology, and US Department of Health and Human Services. Circulation 2014 130 1662 7
9. Page RL, Joglar JA, Al-Khatib SM, 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation 2016 133 e506 74
10. Al-Khatib SM, Arshad A, Balk EM, Risk stratification for arrhythmic events in patients with asymptomatic pre-excitation: a systematic review for the 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society [published ahead of print September 23, 2015]. Circulation 2015. IN PRESS. doi: 10.1161/CIR.0000000000000309.
11. January CT, Wann LS, Alpert JS, 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 2014 130 e199 267
12. Blomström-Lundqvist C, Scheinman MM, Aliot EM, ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias). Developed in collaboration with NASPE-Heart Rhythm Society. Circulation 2003 108 1871 909
13. Orejarena LA, Vidaillet H, DeStefano F, Paroxysmal supraventricular tachycardia in the general population. J Am Coll Cardiol 1998 31 150 7
14. Lu C-W, Wu M-H, Chen H-C, Epidemiological profile of Wolff-Parkinson-White syndrome in a general population younger than 50 years of age in an era of radiofrequency catheter ablation. Int J Cardiol 2014 174 530 4
15. Whinnett ZI, Sohaib SMA, Davies DW, Diagnosis and management of supraventricular tachycardia. BMJ 2012 345 e7769
16. Porter MJ, Morton JB, Denman R, Influence of age and gender on the mechanism of supraventricular tachycardia. Heart Rhythm 2004 1 393 6
17. Goyal R, Zivin A, Souza J, Comparison of the ages of tachycardia onset in patients with atrioventricular nodal reentrant tachycardia and accessory pathway-mediated tachycardia. Am Heart J 1996 132 765 7
18. Maryniak A, Bielawska A, Bieganowska K, Does atrioventricular reentry tachycardia (AVRT) or atrioventricular nodal reentry tachycardia (AVNRT) in children affect their cognitive and emotional development? Pediatr Cardiol 2013 34 893 7
19. González-Torrecilla E, Almendral J, Arenal A, Combined evaluation of bedside clinical variables and the electrocardiogram for the differential diagnosis of paroxysmal atrioventricular reciprocating tachycardias in patients without pre-excitation. J Am Coll Cardiol 2009 53 2353 8
20. Liu S, Yuan S, Hertervig E, Gender and atrioventricular conduction properties of patients with symptomatic atrioventricular nodal reentrant tachycardia and Wolff-Parkinson-White syndrome. J Electrocardiol 2001 34 295 301
21. Anand RG, Rosenthal GL, Van Hare GF, Is the mechanism of supraventricular tachycardia in pediatrics influenced by age, gender or ethnicity? Congenit Heart Dis 2009 4 464 8
22. Walfridsson U, Strömberg A, Janzon M, Wolff-Parkinson-White syndrome and atrioventricular nodal re-entry tachycardia in a Swedish population: consequences on health-related quality of life. Pacing Clin Electrophysiol 2009 32 1299 306
23. Cain N, Irving C, Webber S, Natural history of Wolff-Parkinson-White syndrome diagnosed in childhood. Am J Cardiol 2013 112 961 5
24. Laurent G, Leong-Poi H, Mangat I, Influence of ventriculoatrial timing on hemodynamics and symptoms during supraventricular tachycardia. J Cardiovasc Electrophysiol 2009 20 176 81
25. Auricchio A, Klein H, Trappe HJ, Lack of prognostic value of syncope in patients with Wolff-Parkinson-White syndrome. J Am Coll Cardiol 1991 17 152 8
26. Drago F, Turchetta A, Calzolari A, Reciprocating supraventricular tachycardia in children: low rate at rest as a major factor related to propensity to syncope during exercise. Am Heart J 1996 132 280 5
27. Kalusche D, Ott P, Arentz T, AV nodal re-entry tachycardia in elderly patients: clinical presentation and results of radiofrequency catheter ablation therapy. Coron Artery Dis 1998 9 359 63
28. Haghjoo M, Arya A, Heidari A, Electrophysiologic characteristics and results of radiofrequency catheter ablation in elderly patients with atrioventricular nodal reentrant tachycardia. J Electrocardiol 2007 40 208 13
29. Walfridsson U, Walfridsson H, The impact of supraventricular tachycardias on driving ability in patients referred for radiofrequency catheter ablation. Pacing Clin Electrophysiol 2005 28 191 5
30. Letsas KP, Weber R, Siklody CH, Electrocardiographic differentiation of common type atrioventricular nodal reentrant tachycardia from atrioventricular reciprocating tachycardia via a concealed accessory pathway. Acta Cardiol 2010 65 171 6
31. Knight BP, Ebinger M, Oral H, Diagnostic value of tachycardia features and pacing maneuvers during paroxysmal supraventricular tachycardia. J Am Coll Cardiol 2000 36 574 82
32. Murman DH, McDonald AJ, Pelletier AJ, US emergency department visits for supraventricular tachycardia, 1993-2003. Acad Emerg Med 2007 14 578 81
33. Lim SH, Anantharaman V, Teo WS, Comparison of treatment of supraventricular tachycardia by Valsalva maneuver and carotid sinus massage. Ann Emerg Med 1998 31 30 5
34. Luber S, Brady WJ, Joyce T, Paroxysmal supraventricular tachycardia: outcome after ED care. Am J Emerg Med 2001 19 40 2
35. Waxman MB, Wald RW, Sharma AD, Vagal techniques for termination of paroxysmal supraventricular tachycardia. Am J Cardiol 1980 46 655 64
36. Brady WJ, DeBehnke DJ, Wickman LL, Treatment of out-of-hospital supraventricular tachycardia: adenosine vs verapamil. Acad Emerg Med 1996 3 574 85
37. Cairns CB, Niemann JT, Intravenous adenosine in the emergency department management of paroxysmal supraventricular tachycardia. Ann Emerg Med 1991 20 717 21
38. Gausche M, Persse DE, Sugarman T, Adenosine for the prehospital treatment of paroxysmal supraventricular tachycardia. Ann Emerg Med 1994 24 183 9
39. Madsen CD, Pointer JE, Lynch TG, A comparison of adenosine and verapamil for the treatment of supraventricular tachycardia in the prehospital setting. Ann Emerg Med 1995 25 649 55
40. McCabe JL, Adhar GC, Menegazzi JJ, Intravenous adenosine in the prehospital treatment of paroxysmal supraventricular tachycardia. Ann Emerg Med 1992 21 358 61
41. Rankin AC, Oldroyd KG, Chong E, Value and limitations of adenosine in the diagnosis and treatment of narrow and broad complex tachycardias. Br Heart J 1989 62 195 203
42. Lim SH, Anantharaman V, Teo WS, Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia. Resuscitation 2009 80 523 8
43. DiMarco JP, Miles W, Akhtar M, Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group. Ann Intern Med 1990 113 104 10
44. Roth A, Elkayam I, Shapira I, Effectiveness of prehospital synchronous direct-current cardioversion for supraventricular tachyarrhythmias causing unstable hemodynamic states. Am J Cardiol 2003 91 489 91
45. Stec S, Kryñski T, Kułakowski P, Efficacy of low energy rectilinear biphasic cardioversion for regular atrial tachyarrhythmias. Cardiol J 2011 18 33 8
46. Lim SH, Anantharaman V, Teo WS, Slow-infusion of calcium channel blockers in the emergency management of supraventricular tachycardia. Resuscitation 2002 52 167 74
47. Gupta A, Naik A, Vora A, Comparison of efficacy of intravenous diltiazem and esmolol in terminating supraventricular tachycardia. J Assoc Physicians India 1999 47 969 72
48. Dorian P, Naccarelli GV, Coumel P, A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group. Am J Cardiol 1996 77 89A 95A
49. Mauritson DR, Winniford MD, Walker WS, Oral verapamil for paroxysmal supraventricular tachycardia: a long-term, double-blind randomized trial. Ann Intern Med 1982 96 409 12
50. Winniford MD, Fulton KL, Hillis LD, Long-term therapy of paroxysmal supraventricular tachycardia: a randomized, double-blind comparison of digoxin, propranolol and verapamil. Am J Cardiol 1984 54 1138 9
51. Jackman WM, Beckman KJ, McClelland JH, Treatment of supraventricular tachycardia due to atrioventricular nodal reentry, by radiofrequency catheter ablation of slow-pathway conduction. N Engl J Med 1992 327 313 8
52. Hindricks G, The Multicentre European Radiofrequency Survey (MERFS): complications of radiofrequency catheter ablation of arrhythmias. The Multicentre European Radiofrequency Survey (MERFS) investigators of the Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J 1993 14 1644 53
53. Hindricks G, Incidence of complete atrioventricular block following attempted radiofrequency catheter modification of the atrioventricular node in 880 patients. Results of the Multicenter European Radiofrequency Survey (MERFS) The Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J 1996 17 82 8
54. Spector P, Reynolds MR, Calkins H, Meta-analysis of ablation of atrial flutter and supraventricular tachycardia. Am J Cardiol 2009 104 671 7
55. Calkins H, Yong P, Miller JM, Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group. Circulation 1999 99 262 70
56. Scheinman MM, Huang S, The 1998 NASPE prospective catheter ablation registry. Pacing Clin Electrophysiol 2000 23 1020 8
57. Cheng CH, Sanders GD, Hlatky MA, Cost-effectiveness of radiofrequency ablation for supraventricular tachycardia. Ann Intern Med 2000 133 864 76
58. Bohnen M, Stevenson WG, Tedrow UB, Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias. Heart Rhythm 2011 8 1661 6
59. Tendera M, Wnuk-Wojnar AM, Kulakowski P, Efficacy and safety of dofetilide in the prevention of symptomatic episodes of paroxysmal supraventricular tachycardia: a 6-month double-blind comparison with propafenone and placebo. Am Heart J 2001 142 93 8
60. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation UK Propafenone PSVT Study Group. Circulation 1995 92 2550 7
61. Chimienti M, Cullen MT, Casadei G, Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group. Eur Heart J 1995 16 1943 51
62. Anderson JL, Platt ML, Guarnieri T, Flecainide acetate for paroxysmal supraventricular tachyarrhythmias. The Flecainide Supraventricular Tachycardia Study Group. Am J Cardiol 1994 74 578 84
63. Pritchett EL, DaTorre SD, Platt ML, Flecainide acetate treatment of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation: dose-response studies. The Flecainide Supraventricular Tachycardia Study Group. J Am Coll Cardiol 1991 17 297 303
64. Pritchett EL, McCarthy EA, Wilkinson WE, Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy. Ann Intern Med 1991 114 539 44
65. Henthorn RW, Waldo AL, Anderson JL, Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group. Circulation 1991 83 119 25
66. Wanless RS, Anderson K, Joy M, Multicenter comparative study of the efficacy and safety of sotalol in the prophylactic treatment of patients with paroxysmal supraventricular tachyarrhythmias. Am Heart J 1997 133 441 6
67. Gambhir DS, Bhargava M, Nair M, Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia. Indian Heart J 1996 48 133 7
68. Haines DE, Beheiry S, Akar JG, Heart Rythm Society expert consensus statement on electrophysiology laboratory standards: process, protocols, equipment, personnel, and safety. Heart Rhythm 2014 11 e9 51
69. Knight BP, Zivin A, Souza J, A technique for the rapid diagnosis of atrial tachycardia in the electrophysiology laboratory. J Am Coll Cardiol 1999 33 775 81
70. Horowitz LN, Kay HR, Kutalek SP, Risks and complications of clinical cardiac electrophysiologic studies: a prospective analysis of 1,000 consecutive patients. J Am Coll Cardiol 1987 9 1261 8
71. Asirvatham S, Narayan O, Huang SW, Wood M, Advanced catheter mapping and navigation system. Catheter Ablation of Cardiac Arrhythmias 2006 Philadelphia, PA Saunders/Elsevier 135 61
72. Sporton SC, Earley MJ, Nathan AW, Electroanatomic versus fluoroscopic mapping for catheter ablation procedures: a prospective randomized study. J Cardiovasc Electrophysiol 2004 15 310 5
73. Alvarez M, Tercedor L, Almansa I, Safety and feasibility of catheter ablation for atrioventricular nodal re-entrant tachycardia without fluoroscopic guidance. Heart Rhythm 2009 6 1714 20
74. Casella M, Pelargonio G, Dello RA, "Near-zero" fluoroscopic exposure in supraventricular arrhythmia ablation using the EnSite NavX mapping system: personal experience and review of the literature. J Interv Card Electrophysiol 2011 31 109 18
75. Razminia M, Manankil MF, Eryazici PLS, Nonfluoroscopic catheter ablation of cardiac arrhythmias in adults: feasibility, safety, and efficacy. J Cardiovasc Electrophysiol 2012 23 1078 86
76. Earley MJ, Showkathali R, Alzetani M, Radiofrequency ablation of arrhythmias guided by non-fluoroscopic catheter location: a prospective randomized trial. Eur Heart J 2006 27 1223 9
77. Hindricks G, Willems S, Kautzner J, Effect of electroanatomically guided versus conventional catheter ablation of typical atrial flutter on the fluoroscopy time and resource use: a prospective randomized multicenter study. J Cardiovasc Electrophysiol 2009 20 734 40
78. Xu D, Yang B, Shan Q, Initial clinical experience of remote magnetic navigation system for catheter mapping and ablation of supraventricular tachycardias. J Interv Card Electrophysiol 2009 25 171 4
79. Sommer P, Wojdyla-Hordynska A, Rolf S, Initial experience in ablation of typical atrial flutter using a novel three-dimensional catheter tracking system. Europace 2013 15 578 81
80. Cummings JE, Pacifico A, Drago JL, Alternative energy sources for the ablation of arrhythmias. Pacing Clin Electrophysiol 2005 28 434 43
81. Olshansky B, Sullivan RM, Inappropriate sinus tachycardia. J Am Coll Cardiol 2013 61 793 801
82. Marcus B, Gillette PC, Garson A, Intrinsic heart rate in children and young adults: an index of sinus node function isolated from autonomic control. Am Heart J 1990 119 911 6
83. Jose AD, Collison D, The normal range and determinants of the intrinsic heart rate in man. Cardiovasc Res 1970 4 160 7
84. Alboni P, Malcarne C, Pedroni P, Electrophysiology of normal sinus node with and without autonomic blockade. Circulation 1982 65 1236 42
85. Cappato R, Castelvecchio S, Ricci C, Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation. J Am Coll Cardiol 2012 60 1323 9
86. Benezet-Mazuecos J, Rubio JM, Farré J, Long-term outcomes of ivabradine in inappropriate sinus tachycardia patients: appropriate efficacy or inappropriate patients. Pacing Clin Electrophysiol 2013 36 830 6
87. Ptaszynski P, Kaczmarek K, Ruta J, Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy. Europace 2013 15 116 21
88. Ptaszynski P, Kaczmarek K, Ruta J, Ivabradine in the treatment of inappropriate sinus tachycardia in patients after successful radiofrequency catheter ablation of atrioventricular node slow pathway. Pacing Clin Electrophysiol 2013 36 42 9
89. Ptaszynski P, Kaczmarek K, Ruta J, Ivabradine in combination with metoprolol succinate in the treatment of inappropriate sinus tachycardia. J Cardiovasc Pharmacol Ther 2013 18 338 44
90. Calò L, Rebecchi M, Sette A, Efficacy of ivabradine administration in patients affected by inappropriate sinus tachycardia. Heart Rhythm 2010 7 1318 23
91. Kaplinsky E, Comes FP, Urondo LSV, Efficacy of ivabradine in four patients with inappropriate sinus tachycardia: a three month-long experience based on electrocardiographic, Holter monitoring, exercise tolerance and quality of life assessments. Cardiol J 2010 17 166 71
92. Rakovec P, Treatment of inappropriate sinus tachycardia with ivabradine. Wien Klin Wochenschr 2009 121 715 8
93. Zellerhoff S, Hinterseer M, Felix Krull B, Ivabradine in patients with inappropriate sinus tachycardia. Naunyn Schmiedebergs Arch Pharmacol 2010 382 483 6
94. Man KC, Knight B, Tse HF, Radiofrequency catheter ablation of inappropriate sinus tachycardia guided by activation mapping. J Am Coll Cardiol 2000 35 451 7
95. Lin D, Garcia F, Jacobson J, Use of noncontact mapping and saline-cooled ablation catheter for sinus node modification in medically refractory inappropriate sinus tachycardia. Pacing Clin Electrophysiol 2007 30 236 42
96. Lee RJ, Kalman JM, Fitzpatrick AP, Radiofrequency catheter modification of the sinus node for "inappropriate" sinus tachycardia. Circulation 1995 92 2919 28
97. Marrouche NF, Beheiry S, Tomassoni G, Three-dimensional nonfluoroscopic mapping and ablation of inappropriate sinus tachycardia. Procedural strategies and long-term outcome. J Am Coll Cardiol 2002 39 1046 54
98. Callans DJ, Ren JF, Schwartzman D, Narrowing of the superior vena cava-right atrium junction during radiofrequency catheter ablation for inappropriate sinus tachycardia: analysis with intracardiac echocardiography. J Am Coll Cardiol 1999 33 1667 70
99. Frankel DS, Lin D, Anastasio N, Frequent additional tachyarrhythmias in patients with inappropriate sinus tachycardia undergoing sinus node modification: an important cause of symptom recurrence. J Cardiovasc Electrophysiol 2012 23 835 9
100. Takemoto M, Mukai Y, Inoue S, Usefulness of non-contact mapping for radiofrequency catheter ablation of inappropriate sinus tachycardia: new procedural strategy and long-term clinical outcome. Intern Med 2012 51 357 62
101. Klein I, Ojamaa K, Thyroid hormone and the cardiovascular system. N Engl J Med 2001 344 501 9
102. Steinbeck G, Hoffmann E, 'True' atrial tachycardia. Eur Heart J 1998 19 Suppl E E48 9
103. Wren C, Incessant tachycardias. Eur Heart J 1998 19 Suppl E E54 9
104. Medi C, Kalman JM, Haqqani H, Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia: long-term outcome after catheter ablation. J Am Coll Cardiol 2009 53 1791 7
105. Tang CW, Scheinman MM, Van Hare GF, Use of P wave configuration during atrial tachycardia to predict site of origin. J Am Coll Cardiol 1995 26 1315 24
106. Kistler PM, Roberts-Thomson KC, Haqqani HM, P-wave morphology in focal atrial tachycardia: development of an algorithm to predict the anatomic site of origin. J Am Coll Cardiol 2006 48 1010 7
107. Chen SA, Chiang CE, Yang CJ, Sustained atrial tachycardia in adult patients. Electrophysiological characteristics, pharmacological response, possible mechanisms, and effects of radiofrequency ablation. Circulation 1994 90 1262 78
108. Kalman JM, Olgin JE, Karch MR, "Cristal tachycardias": origin of right atrial tachycardias from the crista terminalis identified by intracardiac echocardiography. J Am Coll Cardiol 1998 31 451 9
109. Morton JB, Sanders P, Das A, Focal atrial tachycardia arising from the tricuspid annulus: electrophysiologic and electrocardiographic characteristics. J Cardiovasc Electrophysiol 2001 12 653 9
110. Kistler PM, Sanders P, Fynn SP, Electrophysiological and electrocardiographic characteristics of focal atrial tachycardia originating from the pulmonary veins: acute and long-term outcomes of radiofrequency ablation. Circulation 2003 108 1968 75
111. Kistler PM, Sanders P, Hussin A, Focal atrial tachycardia arising from the mitral annulus: electrocardiographic and electrophysiologic characterization. J Am Coll Cardiol 2003 41 2212 9
112. Gonzalez MD, Contreras LJ, Jongbloed MRM, Left atrial tachycardia originating from the mitral annulus-aorta junction. Circulation 2004 110 3187 92
113. Kistler PM, Fynn SP, Haqqani H, Focal atrial tachycardia from the ostium of the coronary sinus: electrocardiographic and electrophysiological characterization and radiofrequency ablation. J Am Coll Cardiol 2005 45 1488 93
114. Ouyang F, Ma J, Ho SY, Focal atrial tachycardia originating from the non-coronary aortic sinus: electrophysiological characteristics and catheter ablation. J Am Coll Cardiol 2006 48 122 31
115. Roberts-Thomson KC, Kistler PM, Haqqani HM, Focal atrial tachycardias arising from the right atrial appendage: electrocardiographic and electrophysiologic characteristics and radiofrequency ablation. J Cardiovasc Electrophysiol 2007 18 367 72
116. Biviano AB, Bain W, Whang W, Focal left atrial tachycardias not associated with prior catheter ablation for atrial fibrillation: clinical and electrophysiological characteristics. Pacing Clin Electrophysiol 2012 35 17 27
117. Walters TE, Kistler PM, Kalman JM, Radiofrequency ablation for atrial tachycardia and atrial flutter. Heart Lung Circ 2012 21 386 94
118. Lee G, Sanders P, Kalman JM, Catheter ablation of atrial arrhythmias: state of the art. Lancet 2012 380 1509 19
119. Gillette PC, Garson A Jr, Electrophysiologic and pharmacologic characteristics of automatic ectopic atrial tachycardia. Circulation 1977 56 571 5
120. Mehta AV, Sanchez GR, Sacks EJ, Ectopic automatic atrial tachycardia in children: clinical characteristics, management and follow-up. J Am Coll Cardiol 1988 11 379 85
121. Markowitz SM, Stein KM, Mittal S, Differential effects of adenosine on focal and macroreentrant atrial tachycardia. J Cardiovasc Electrophysiol 1999 10 489 502
122. Reisinger J, Gstrein C, Winter T, Optimization of initial energy for cardioversion of atrial tachyarrhythmias with biphasic shocks. Am J Emerg Med 2010 28 159 65
123. Engelstein ED, Lippman N, Stein KM, Mechanism-specific effects of adenosine on atrial tachycardia. Circulation 1994 89 2645 54
124. Eidher U, Freihoff F, Kaltenbrunner W, Efficacy and safety of ibutilide for the conversion of monomorphic atrial tachycardia. Pacing Clin Electrophysiol 2006 29 358 62
125. de Loma-Osorio F, Diaz-Infante E, Spanish Catheter Ablation Registry. 12th Official Report of the Spanish Society of Cardiology Working Group on Electrophysiology and Arrhythmias (2012). Rev Esp Cardiol (Engl Ed) 2013 66 983 92
126. Liu X, Dong J, Ho SY, Atrial tachycardia arising adjacent to noncoronary aortic sinus: distinctive atrial activation patterns and anatomic insights. J Am Coll Cardiol 2010 56 796 804
127. Creamer JE, Nathan AW, Camm AJ, Successful treatment of atrial tachycardias with flecainide acetate. Br Heart J 1985 53 164 6
128. Kunze KP, Kuck KH, Schlüter M, Effect of encainide and flecainide on chronic ectopic atrial tachycardia. J Am Coll Cardiol 1986 7 1121 6
129. von Bernuth G, Engelhardt W, Kramer HH, Atrial automatic tachycardia in infancy and childhood. Eur Heart J 1992 13 1410 5
130. Lucet V, Do Ngoc D, Fidelle J, [Anti-arrhythmia efficacy of propafenone in children. Apropos of 30 cases]. Arch Mal Coeur Vaiss 1987 80 1385 93
131. Heusch A, Kramer HH, Krogmann ON, Clinical experience with propafenone for cardiac arrhythmias in the young. Eur Heart J 1994 15 1050 6
132. Colloridi V, Perri C, Ventriglia F, Oral sotalol in pediatric atrial ectopic tachycardia. Am Heart J 1992 123 254 6
133. Guccione P, Paul T, Garson A Jr, Long-term follow-up of amiodarone therapy in the young: continued efficacy, unimpaired growth, moderate side effects. J Am Coll Cardiol 1990 15 1118 24
134. Coumel P, Fidelle J, Amiodarone in the treatment of cardiac arrhythmias in children: one hundred thirty-five cases. Am Heart J 1980 100 1063 9
135. Miyazaki A, Ohuchi H, Kurosaki K, Efficacy and safety of sotalol for refractory tachyarrhythmias in congenital heart disease. Circ J 2008 72 1998 2003
136. Kang KT, Etheridge SP, Kantoch MJ, Current management of focal atrial tachycardia in children: a multicenter experience. Circ Arrhythm Electrophysiol 2014 7 664 70
137. Wang K, Goldfarb BL, Gobel FL, Multifocal atrial tachycardia. Arch Intern Med 1977 137 161 4
138. Bittar G, Friedman HS, The arrhythmogenicity of theophylline. A multivariate analysis of clinical determinants. Chest 1991 99 1415 20
139. Iseri LT, Fairshter RD, Hardemann JL, Magnesium and potassium therapy in multifocal atrial tachycardia. Am Heart J 1985 110 789 94
140. Kastor JA, Multifocal atrial tachycardia. N Engl J Med 1990 322 1713 7
141. Arsura EL, Solar M, Lefkin AS, Metoprolol in the treatment of multifocal atrial tachycardia. Crit Care Med 1987 15 591 4
142. Levine JH, Michael JR, Guarnieri T, Treatment of multifocal atrial tachycardia with verapamil. N Engl J Med 1985 312 21 5
143. Salerno DM, Anderson B, Sharkey PJ, Intravenous verapamil for treatment of multifocal atrial tachycardia with and without calcium pretreatment. Ann Intern Med 1987 107 623 8
144. Hazard PB, Burnett CR, Verapamil in multifocal atrial tachycardia. Hemodynamic and respiratory changes. Chest 1987 91 68 70
145. Hazard PB, Burnett CR, Treatment of multifocal atrial tachycardia with metoprolol. Crit Care Med 1987 15 20 5
146. Mehta D, Wafa S, Ward DE, Relative efficacy of various physical manoeuvres in the termination of junctional tachycardia. Lancet 1988 1 1181 5
147. Wen ZC, Chen SA, Tai CT, Electrophysiological mechanisms and determinants of vagal maneuvers for termination of paroxysmal supraventricular tachycardia. Circulation 1998 98 2716 23
148. Glatter KA, Cheng J, Dorostkar P, Electrophysiologic effects of adenosine in patients with supraventricular tachycardia. Circulation 1999 99 1034 40
149. Dougherty AH, Jackman WM, Naccarelli GV, Acute conversion of paroxysmal supraventricular tachycardia with intravenous diltiazem. IV Diltiazem Study Group. Am J Cardiol 1992 70 587 92
150. Waxman HL, Myerburg RJ, Appel R, Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter: a double-blind randomized cross-over study. Ann Intern Med 1981 94 1 6
151. Amsterdam EA, Kulcyski J, Ridgeway MG, Efficacy of cardioselective beta-adrenergic blockade with intravenously administered metoprolol in the treatment of supraventricular tachyarrhythmias. J Clin Pharmacol 1991 31 714 8
152. Das G, Tschida V, Gray R, Efficacy of esmolol in the treatment and transfer of patients with supraventricular tachyarrhythmias to alternate oral antiarrhythmic agents. J Clin Pharmacol 1988 28 746 50
153. Alboni P, Tomasi C, Menozzi C, Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia. J Am Coll Cardiol 2001 37 548 53
154. Yeh SJ, Lin FC, Chou YY, Termination of paroxysmal supraventricular tachycardia with a single oral dose of diltiazem and propranolol. Circulation 1985 71 104 9
155. Rinkenberger RL, Prystowsky EN, Heger JJ, Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias. Circulation 1980 62 996 1010
156. D'Este D, Zoppo F, Bertaglia E, Long-term outcome of patients with atrioventricular node reentrant tachycardia. Int J Cardiol 2007 115 350 3
157. Langberg JJ, Leon A, Borganelli M, A randomized, prospective comparison of anterior and posterior approaches to radiofrequency catheter ablation of atrioventricular nodal reentry tachycardia. Circulation 1993 87 1551 6
158. Kalbfleisch SJ, Strickberger SA, Williamson B, Randomized comparison of anatomic and electrogram mapping approaches to ablation of the slow pathway of atrioventricular node reentrant tachycardia. J Am Coll Cardiol 1994 23 716 23
159. Kay GN, Epstein AE, Dailey SM, Selective radiofrequency ablation of the slow pathway for the treatment of atrioventricular nodal reentrant tachycardia. Evidence for involvement of perinodal myocardium within the reentrant circuit. Circulation 1992 85 1675 88
160. Bogun F, Knight B, Weiss R, Slow pathway ablation in patients with documented but noninducible paroxysmal supraventricular tachycardia. J Am Coll Cardiol 1996 28 1000 4
161. O'Hara GE, Philippon F, Champagne J, Catheter ablation for cardiac arrhythmias: a 14-year experience with 5330 consecutive patients at the Quebec Heart Institute, Laval Hospital. Can J Cardiol 2007 23 Suppl B 67B 70B
162. Gambhir DS, Bhargava M, Arora R, Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia. Indian Heart J 1995 47 237 43
163. Musto B, Cavallaro C, Musto A, Flecainide single oral dose for management of paroxysmal supraventricular tachycardia in children and young adults. Am Heart J 1992 124 110 5
164. Munger TM, Packer DL, Hammill SC, A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953-1989. Circulation 1993 87 866 73
165. Pappone C, Vicedomini G, Manguso F, Wolff-Parkinson-white syndrome in the era of catheter ablation: insights from a registry study of 2169 patients. Circulation 2014 130 811 9
166. Timmermans C, Smeets JL, Rodriguez LM, Aborted sudden death in the Wolff-Parkinson-White syndrome. Am J Cardiol 1995 76 492 4
167. Klein GJ, Bashore TM, Sellers TD, Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med 1979 301 1080 5
168. Bromberg BI, Lindsay BD, Cain ME, Impact of clinical history and electrophysiologic characterization of accessory pathways on management strategies to reduce sudden death among children with Wolff-Parkinson-White syndrome. J Am Coll Cardiol 1996 27 690 5
169. Santinelli V, Radinovic A, Manguso F, The natural history of asymptomatic ventricular pre-excitation a long-term prospective follow-up study of 184 asymptomatic children. J Am Coll Cardiol 2009 53 275 80
170. Neumar RW, Otto CW, Link MS, Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010 122 S729 67
171. Smith GD, Dyson K, Taylor D, Effectiveness of the Valsalva Manoeuvre for reversion of supraventricular tachycardia. Cochrane Database Syst Rev 2013 3 CD009502
172. Delaney B, Loy J, Kelly A-M, The relative efficacy of adenosine versus verapamil for the treatment of stable paroxysmal supraventricular tachycardia in adults: a meta-analysis. Eur J Emerg Med 2011 18 148 52
173. Furlong R, Gerhardt RT, Farber P, Intravenous adenosine as first-line prehospital management of narrow-complex tachycardias by EMS personnel without direct physician control. Am J Emerg Med 1995 13 383 8
174. Schatz I, Ordog GJ, Karody R, Wolff-Parkinson-White syndrome presenting in atrial fibrillation. Ann Emerg Med 1987 16 574 8
175. Mittal S, Ayati S, Stein KM, Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Circulation 2000 101 1282 7
176. Glatter KA, Dorostkar PC, Yang Y, Electrophysiological effects of ibutilide in patients with accessory pathways. Circulation 2001 104 1933 9
177. Sellers TD Jr., Campbell RW, Bashore TM, Effects of procainamide and quinidine sulfate in the Wolff-Parkinson-White syndrome. Circulation 1977 55 15 22
178. Huycke EC, Sung RJ, Dias VC, Intravenous diltiazem for termination of reentrant supraventricular tachycardia: a placebo-controlled, randomized, double-blind, multicenter study. J Am Coll Cardiol 1989 13 538 44
179. Hamer A, Peter T, Platt M, Effects of verapamil on supraventricular tachycardia in patients with overt and concealed Wolff-Parkinson-White syndrome. Am Heart J 1981 101 600 12
180. Hombach V, Braun V, Hopp HW, Antiarrhythmic effects of acute betablockade with atenolol on supraventricular tachycardias at rest and during exercise. Klin Wochenschr 1981 59 123 33
181. Morady F, DiCarlo LA Jr., Baerman JM, Effect of propranolol on ventricular rate during atrial fibrillation in the Wolff-Parkinson-White syndrome. Pacing Clin Electrophysiol 1987 10 492 6
182. Sellers TD Jr., Bashore TM, Gallagher JJ, Digitalis in the pre-excitation syndrome. Analysis during atrial fibrillation. Circulation 1977 56 260 7
183. Sheinman BD, Evans T, Acceleration of ventricular rate by fibrillation associated with the Wolff-Parkinson-White syndrome. Br Med J (Clin Res Ed) 1982 285 999 1000
184. Boriani G, Biffi M, Frabetti L, Ventricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation. Am Heart J 1996 131 1214 6
185. Shiraishi H, Ishibashi K, Urao N, Two cases of polymorphic ventricular tachycardia induced by the administration of verapamil against paroxysmal supraventricular tachycardia. Intern Med 2002 41 445 8
186. Schützenberger W, Leisch F, Gmeiner R, Enhanced accessory pathway conduction following intravenous amiodarone in atrial fibrillation. A case report. Int J Cardiol 1987 16 93 5
187. Jackman WM, Wang XZ, Friday KJ, Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. N Engl J Med 1991 324 1605 11
188. Calkins H, Langberg J, Sousa J, Radiofrequency catheter ablation of accessory atrioventricular connections in 250 patients. Abbreviated therapeutic approach to Wolff-Parkinson-White syndrome. Circulation 1992 85 1337 46
189. Dagres N, Clague JR, Kottkamp H, Radiofrequency catheter ablation of accessory pathways. Outcome and use of antiarrhythmic drugs during follow-up. Eur Heart J 1999 20 1826 32
190. Schläpfer J, Fromer M, Late clinical outcome after successful radiofrequency catheter ablation of accessory pathways. Eur Heart J 2001 22 605 9
191. Belhassen B, Rogowski O, Glick A, Radiofrequency ablation of accessory pathways: a 14 year experience at the Tel Aviv Medical Center in 508 patients. Isr Med Assoc J 2007 9 265 70
192. Kugler JD, Danford DA, Deal BJ, Radiofrequency catheter ablation for tachyarrhythmias in children and adolescents. The Pediatric Electrophysiology Society. N Engl J Med 1994 330 1481 7
193. Kugler JD, Danford DA, Houston K, Radiofrequency catheter ablation for paroxysmal supraventricular tachycardia in children and adolescents without structural heart disease. Pediatric EP Society, Radiofrequency Catheter Ablation Registry. Am J Cardiol 1997 80 1438 43
194. Sakurai M, Yasuda H, Kato N, Acute and chronic effects of verapamil in patients with paroxysmal supraventricular tachycardia. Am Heart J 1983 105 619 28
195. Hopson JR, Buxton AE, Rinkenberger RL, Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group. Am J Cardiol 1996 77 72A 82A
196. Feld GK, Nademanee K, Weiss J, Electrophysiologic basis for the suppression by amiodarone of orthodromic supraventricular tachycardias complicating pre-excitation syndromes. J Am Coll Cardiol 1984 3 1298 307
197. Feld GK, Nademanee K, Stevenson W, Clinical and electrophysiologic effects of amiodarone in patients with atrial fibrillation complicating the Wolff-Parkinson-White syndrome. Am Heart J 1988 115 102 7
198. Bauernfeind RA, Wyndham CR, Dhingra RC, Serial electrophysiologic testing of multiple drugs in patients with atrioventricular nodal reentrant paroxysmal tachycardia. Circulation 1980 62 1341 9
199. Sharma AD, Yee R, Guiraudon G, Sensitivity and specificity of invasive and noninvasive testing for risk of sudden death in Wolff-Parkinson-White syndrome. J Am Coll Cardiol 1987 10 373 81
200. Gaita F, Giustetto C, Riccardi R, Stress and pharmacologic tests as methods to identify patients with Wolff-Parkinson-White syndrome at risk of sudden death. Am J Cardiol 1989 64 487 90
201. Spar DS, Silver ES, Hordof AJ, Relation of the utility of exercise testing for risk assessment in pediatric patients with ventricular preexcitation to pathway location. Am J Cardiol 2012 109 1011 4
202. Wackel P, Irving C, Webber S, Risk stratification in Wolff-Parkinson-White syndrome: the correlation between noninvasive and invasive testing in pediatric patients. Pacing Clin Electrophysiol 2012 35 1451 7
203. Beckman KJ, Gallastegui JL, Bauman JL, The predictive value of electrophysiologic studies in untreated patients with Wolff-Parkinson-White syndrome. J Am Coll Cardiol 1990 15 640 7
204. Pappone C, Vicedomini G, Manguso F, Risk of malignant arrhythmias in initially symptomatic patients with Wolff-Parkinson-White syndrome: results of a prospective long-term electrophysiological follow-up study. Circulation 2012 125 661 8
205. Rinne C, Klein GJ, Sharma AD, Relation between clinical presentation and induced arrhythmias in the Wolff-Parkinson-White syndrome. Am J Cardiol 1987 60 576 9
206. Brembilla-Perrot B, Holban I, Houriez P, Influence of age on the potential risk of sudden death in asymptomatic Wolff-Parkinson-White syndrome. Pacing Clin Electrophysiol 2001 24 1514 8
207. Pappone C, Santinelli V, Manguso F, A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White syndrome. N Engl J Med 2003 349 1803 11
208. Pappone C, Santinelli V, Rosanio S, Usefulness of invasive electrophysiologic testing to stratify the risk of arrhythmic events in asymptomatic patients with Wolff-Parkinson-White pattern: results from a large prospective long-term follow-up study. J Am Coll Cardiol 2003 41 239 44
209. Epstein AE, Miles WM, Benditt DG, Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations. A medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology. Circulation 1996 94 1147 66
210. Klein GJ, Yee R, Sharma AD, Longitudinal electrophysiologic assessment of asymptomatic patients with the Wolff-Parkinson-White electrocardiographic pattern. N Engl J Med 1989 320 1229 33
211. Leitch JW, Klein GJ, Yee R, Prognostic value of electrophysiology testing in asymptomatic patients with Wolff-Parkinson-White pattern. Circulation 1990 82 1718 23
212. Milstein S, Sharma AD, Klein GJ, Electrophysiologic profile of asymptomatic Wolff-Parkinson-White pattern. Am J Cardiol 1986 57 1097 100
213. Satoh M, Aizawa Y, Funazaki T, Electrophysiologic evaluation of asymptomatic patients with the Wolff-Parkinson-White pattern. Pacing Clin Electrophysiol 1989 12 413 20
214. Havránek S, Simek J, St'ovícek P, Distribution of mean cycle length in cavo-tricuspid isthmus dependent atrial flutter. Physiol Res 2012 61 43 51
215. Waldo AL, Feld GK, Inter-relationships of atrial fibrillation and atrial flutter mechanisms and clinical implications. J Am Coll Cardiol 2008 51 779 86
216. Pérez FJ, Schubert CM, Parvez B, Long-term outcomes after catheter ablation of cavo-tricuspid isthmus dependent atrial flutter: a meta-analysis. Circ Arrhythm Electrophysiol 2009 2 393 401
217. Ellis K, Wazni O, Marrouche N, Incidence of atrial fibrillation post-cavotricuspid isthmus ablation in patients with typical atrial flutter: left-atrial size as an independent predictor of atrial fibrillation recurrence. J Cardiovasc Electrophysiol 2007 18 799 802
218. Hsieh M-H, Tai C-T, Chiang C-E, Recurrent atrial flutter and atrial fibrillation after catheter ablation of the cavotricuspid isthmus: a very long-term follow-up of 333 patients. J Interv Card Electrophysiol 2002 7 225 31
219. Tai CT, Chen SA, Chiang CE, Long-term outcome of radiofrequency catheter ablation for typical atrial flutter: risk prediction of recurrent arrhythmias. J Cardiovasc Electrophysiol 1998 9 115 21
220. Paydak H, Kall JG, Burke MC, Atrial fibrillation after radiofrequency ablation of type I atrial flutter: time to onset, determinants, and clinical course. Circulation 1998 98 315 22
221. Chinitz JS, Gerstenfeld EP, Marchlinski FE, Atrial fibrillation is common after ablation of isolated atrial flutter during long-term follow-up. Heart Rhythm 2007 4 1029 33
222. Teh AW, Medi C, Lee G, Long-term outcome following ablation of atrial flutter occurring late after atrial septal defect repair. Pacing Clin Electrophysiol 2011 34 431 5
223. Gerstenfeld EP, Callans DJ, Dixit S, Mechanisms of organized left atrial tachycardias occurring after pulmonary vein isolation. Circulation 2004 110 1351 7
224. Chugh A, Oral H, Lemola K, Prevalence, mechanisms, and clinical significance of macroreentrant atrial tachycardia during and following left atrial ablation for atrial fibrillation. Heart Rhythm 2005 2 464 71
225. Veenhuyzen GD, Knecht S, O'Neill MD, Atrial tachycardias encountered during and after catheter ablation for atrial fibrillation: part I: classification, incidence, management. Pacing Clin Electrophysiol 2009 32 393 8
226. Karch MR, Zrenner B, Deisenhofer I, Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies. Circulation 2005 111 2875 80
227. Sawhney N, Anousheh R, Chen W, Circumferential pulmonary vein ablation with additional linear ablation results in an increased incidence of left atrial flutter compared with segmental pulmonary vein isolation as an initial approach to ablation of paroxysmal atrial fibrillation. Circ Arrhythm Electrophysiol 2010 3 243 8
228. Neumann T, Vogt J, Schumacher B, Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study. J Am Coll Cardiol 2008 52 273 8
229. Ellenbogen KA, Stambler BS, Wood MA, Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study. J Am Coll Cardiol 1996 28 130 6
230. Suttorp MJ, Kingma JH, Jessurun ER, The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. J Am Coll Cardiol 1990 16 1722 7
231. Stambler BS, Wood MA, Ellenbogen KA, Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators. Circulation 1996 94 1613 21
232. Kingma JH, Suttorp MJ, Acute pharmacologic conversion of atrial fibrillation and flutter: the role of flecainide, propafenone, and verapamil. Am J Cardiol 1992 70 56A 60A
233. Vos MA, Golitsyn SR, Stangl K, Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group. Heart 1998 79 568 75
234. Volgman AS, Carberry PA, Stambler B, Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. J Am Coll Cardiol 1998 31 1414 9
235. Steinwender C, Hönig S, Kypta A, Pre-injection of magnesium sulfate enhances the efficacy of ibutilide for the conversion of typical but not of atypical persistent atrial flutter. Int J Cardiol 2010 141 260 5
236. Singh S, Zoble RG, Yellen L, Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study. Circulation 2000 102 2385 90
237. Blackshear JL, Stambler BS, Strauss WE, Control of heart rate during transition from intravenous to oral diltiazem in atrial fibrillation or flutter. Am J Cardiol 1996 78 1246 50
238. Singh BN, Hecht HS, Nademanee K, Electrophysiologic and hemodynamic effects of slow-channel blocking drugs. Prog Cardiovasc Dis 1982 25 103 32
239. Akhtar M, Tchou P, Jazayeri M, Use of calcium channel entry blockers in the treatment of cardiac arrhythmias. Circulation 1989 80 IV31 9
240. Delle Karth G, Geppert A, Neunteufl T, Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias. Crit Care Med 2001 29 1149 53
241. Ellenbogen KA, Dias VC, Plumb VJ, A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: a multicenter study. J Am Coll Cardiol 1991 18 891 7
242. Ellenbogen KA, Dias VC, Cardello FP, Safety and efficacy of intravenous diltiazem in atrial fibrillation or atrial flutter. Am J Cardiol 1995 75 45 9
243. Platia EV, Michelson EL, Porterfield JK, Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter. Am J Cardiol 1989 63 925 9
244. Salerno DM, Dias VC, Kleiger RE, Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter. The Diltiazem-Atrial Fibrillation/Flutter Study Group. Am J Cardiol 1989 63 1046 51
245. Gallagher MM, Guo XH, Poloniecki JD, Initial energy setting, outcome and efficiency in direct current cardioversion of atrial fibrillation and flutter. J Am Coll Cardiol 2001 38 1498 504
246. Botkin SB, Dhanekula LS, Olshansky B, Outpatient cardioversion of atrial arrhythmias: efficacy, safety, and costs. Am Heart J 2003 145 233 8
247. Pizzale S, Lemery R, Green MS, Frequency and predictors of tachycardia-induced cardiomyopathy in patients with persistent atrial flutter. Can J Cardiol 2009 25 469 72
248. Van Gelder IC, Crijns HJ, Van Gilst WH, Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol 1991 68 41 6
249. Boriani G, Tukkie R, Manolis AS, Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial. Eur Heart J 2014 35 2352 62
250. Mitchell ARJ, Spurrell PAR, Cheatle L, Effect of atrial antitachycardia pacing treatments in patients with an atrial defibrillator: randomised study comparing subthreshold and nominal pacing outputs. Heart 2002 87 433 7
251. Gillis AM, Unterberg-Buchwald C, Schmidinger H, Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator. J Am Coll Cardiol 2002 40 1653 9
252. Waldo AL, MacLean WA, Cooper TB, Use of temporarily placed epicardial atrial wire electrodes for the diagnosis and treatment of cardiac arrhythmias following open-heart surgery. J Thorac Cardiovasc Surg 1978 76 500 5
253. Peters RW, Shorofsky SR, Pelini M, Overdrive atrial pacing for conversion of atrial flutter: comparison of postoperative with nonpostoperative patients. Am Heart J 1999 137 100 3
254. Ghali WA, Wasil BI, Brant R, Atrial flutter and the risk of thromboembolism: a systematic review and meta-analysis. Am J Med 2005 118 101 7
255. Clemo HF, Wood MA, Gilligan DM, Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias. Am J Cardiol 1998 81 594 8
256. Roberts SA, Diaz C, Nolan PE, Effectiveness and costs of digoxin treatment for atrial fibrillation and flutter. Am J Cardiol 1993 72 567 73
257. Natale A, Newby KH, Pisanó E, Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter. J Am Coll Cardiol 2000 35 1898 904
258. Bastani H, Drca N, Insulander P, Cryothermal vs. radiofrequency ablation as atrial flutter therapy: a randomized comparison. Europace 2013 15 420 8
259. Poty H, Saoudi N, Nair M, Radiofrequency catheter ablation of atrial flutter. Further insights into the various types of isthmus block: application to ablation during sinus rhythm. Circulation 1996 94 3204 13
260. Schwartzman D, Callans DJ, Gottlieb CD, Conduction block in the inferior vena caval-tricuspid valve isthmus: association with outcome of radiofrequency ablation of type I atrial flutter. J Am Coll Cardiol 1996 28 1519 31
261. Delacretaz E, Ganz LI, Soejima K, Multi atrial maco-re-entry circuits in adults with repaired congenital heart disease: entrainment mapping combined with three-dimensional electroanatomic mapping. J Am Coll Cardiol 2001 37 1665 76
262. Jaïs P, Shah DC, Haïssaguerre M, Mapping and ablation of left atrial flutters. Circulation 2000 101 2928 34
263. Da Costa A, Thevenin J, Roche F, Results from the Loire-Ardeche-Drome-Isere-Puy-de-Dome (LADIP) trial on atrial flutter, a multicentric prospective randomized study comparing amiodarone and radiofrequency ablation after the first episode of symptomatic atrial flutter. Circulation 2006 114 1676 81
264. Pedersen OD, Bagger H, Keller N, Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy. Circulation 2001 104 292 6
265. Benditt DG, Williams JH, Jin J, Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d,l-Sotalol Atrial Fibrillation/Flutter Study Group. Am J Cardiol 1999 84 270 7
266. Reithmann C, Hoffmann E, Spitzlberger G, Catheter ablation of atrial flutter due to amiodarone therapy for paroxysmal atrial fibrillation. Eur Heart J 2000 21 565 72
267. Huang DT, Monahan KM, Zimetbaum P, Hybrid pharmacologic and ablative therapy: a novel and effective approach for the management of atrial fibrillation. J Cardiovasc Electrophysiol 1998 9 462 9
268. Schumacher B, Jung W, Lewalter T, Radiofrequency ablation of atrial flutter due to administration of class IC antiarrhythmic drugs for atrial fibrillation. Am J Cardiol 1999 83 710 3
269. Mohanty S, Mohanty P, Di Biase L, Results from a single-blind, randomized study comparing the impact of different ablation approaches on long-term procedure outcome in coexistent atrial fibrillation and flutter (APPROVAL). Circulation 2013 127 1853 60
270. Wazni O, Marrouche NF, Martin DO, Randomized study comparing combined pulmonary vein-left atrial junction disconnection and cavotricuspid isthmus ablation versus pulmonary vein-left atrial junction disconnection alone in patients presenting with typical atrial flutter and atrial fibrillation. Circulation 2003 108 2479 83
271. Coffey JO, d'Avila A, Dukkipati S, Catheter ablation of scar-related atypical atrial flutter. Europace 2013 15 414 9
272. Aliot E, Denjoy I, Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group. Am J Cardiol 1996 77 66A 71A
273. Van Gelder IC, Crijns HJ, Van Gilst WH, Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter. Am J Cardiol 1989 64 1317 21
274. Pietersen AH, Hellemann H, Usefulness of flecainide for prevention of paroxysmal atrial fibrillation and flutter. Danish-Norwegian Flecainide Multicenter Study Group. Am J Cardiol 1991 67 713 7
275. Ruder MA, Davis JC, Eldar M, Clinical and electrophysiologic characterization of automatic junctional tachycardia in adults. Circulation 1986 73 930 937
276. Wyndham CR, Dhingra RC, Smith T, Concealed nonparoxysmal junctional tachycardia. Circulation 1979 60 707 710
277. Konecke LL, Knoebel SB, Nonparoxysmal junctional tachycardia complicating acute myocardial infarction. Circulation 1972 45 367 74
278. Fishenfeld J, Desser KB, Benchimol A, Non-paroxysmal A-V junctional tachycardia associated with acute myocardial infarction. Am Heart J 1973 86 754 8
279. Kumagai K, Yamato H, Yamanouchi Y, Automatic junctional tachycardia in an adult. Clin Cardiol 1990 13 813 6
280. Cook JR, Steinberg JS, An incessant form of junctional ectopic tachycardia in an adult responsive to a class 1C agent. Am Heart J 1991 122 1487 9
281. Kuck KH, Kunze KP, Schlüter M, Encainide versus flecainide for chronic atrial and junctional ectopic tachycardia. Am J Cardiol 1988 62 37L 44L
282. Mamchur SE, Kurilin MY, High-amplitude pace mapping increases safety of radiofrequency catheter ablation of parahisian ectopic foci. Pacing Clin Electrophysiol 2012 35 1458 63
283. Padanilam BJ, Manfredi JA, Steinberg LA, Differentiating junctional tachycardia and atrioventricular node re-entry tachycardia based on response to atrial extrastimulus pacing. J Am Coll Cardiol 2008 52 1711 7
284. Scheinman MM, Gonzalez RP, Cooper MW, Clinical and electrophysiologic features and role of catheter ablation techniques in adult patients with automatic atrioventricular junctional tachycardia. Am J Cardiol 1994 74 565 72
285. Fan R, Tardos JG, Almasry I, Novel use of atrial overdrive pacing to rapidly differentiate junctional tachycardia from atrioventricular nodal reentrant tachycardia. Heart Rhythm 2011 8 840 4
286. Srivathsan K, Gami AS, Barrett R, Differentiating atrioventricular nodal reentrant tachycardia from junctional tachycardia: novel application of the delta H-A interval. J Cardiovasc Electrophysiol 2008 19 1 6
287. Hamdan M, Van Hare GF, Fisher W, Selective catheter ablation of the tachycardia focus in patients with nonreentrant junctional tachycardia. Am J Cardiol 1996 78 1292 7
288. Law IH, Von Bergen NH, Gingerich JC, Transcatheter cryothermal ablation of junctional ectopic tachycardia in the normal heart. Heart Rhythm 2006 3 903 7
289. Garson A Jr., Gillette PC, Electrophysiologic studies of supraventricular tachycardia in children. I. Clinical-electrophysiologic correlations. Am Heart J 1981 102 233 50
290. Ko JK, Deal BJ, Strasburger JF, Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Am J Cardiol 1992 69 1028 32
291. Weindling SN, Saul JP, Walsh EP, Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants. Am Heart J 1996 131 66 72
292. Garson A Jr., Gillette PC, McNamara DG, Supraventricular tachycardia in children: clinical features, response to treatment, and long-term follow-up in 217 patients. J Pediatr 1981 98 875 82
293. Dixon J, Foster K, Wyllie J, Guidelines and adenosine dosing in supraventricular tachycardia. Arch Dis Child 2005 90 1190 1
294. Díaz-Parra S, Sánchez-Yañez P, Zabala-Argüelles I, Use of adenosine in the treatment of supraventricular tachycardia in a pediatric emergency department. Pediatr Emerg Care 2014 30 388 93
295. Losek JD, Endom E, Dietrich A, Adenosine and pediatric supraventricular tachycardia in the emergency department: multicenter study and review. Ann Emerg Med 1999 33 185 91
296. Deal BJ, Keane JF, Gillette PC, Wolff-Parkinson-White syndrome and supraventricular tachycardia during infancy: management and follow-up. J Am Coll Cardiol 1985 5 130 5
297. Villain E, Bonnet D, Acar P, [Recommendations for the treatment of recurrent supraventricular tachycardia in infants]. Arch Pediatr 1998 5 133 8
298. Fish FA, Gillette PC, Benson DW Jr., Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group. J Am Coll Cardiol 1991 18 356 65
299. Lee P-C, Hwang B, Chen S-A, The results of radiofrequency catheter ablation of supraventricular tachycardia in children. Pacing Clin Electrophysiol 2007 30 655 61
300. Van Hare GF, Javitz H, Carmelli D, Prospective assessment after pediatric cardiac ablation: demographics, medical profiles, and initial outcomes. J Cardiovasc Electrophysiol 2004 15 759 70
301. Aiyagari R, Saarel EV, Etheridge SP, Radiofrequency ablation for supraventricular tachycardia in children < or =15 kg is safe and effective. Pediatr Cardiol 2005 26 622 6
302. Blaufox AD, Felix GL, Saul JP, Radiofrequency catheter ablation in infants
303. Blaufox AD, Paul T, Saul JP, Radiofrequency catheter ablation in small children: relationship of complications to application dose. Pacing Clin Electrophysiol 2004 27 224 9
304. Kantoch MJ, Gulamhusein SS, Sanatani S, Short- and long-term outcomes in children undergoing radiofrequency catheter ablation before their second birthday. Can J Cardiol 2011 27 523.e3 9
305. Schaffer MS, Gow RM, Moak JP, Mortality following radiofrequency catheter ablation (from the Pediatric Radiofrequency Ablation Registry). Participating members of the Pediatric Electrophysiology Society. Am J Cardiol 2000 86 639 43
306. Collins KK, Van Hare GF, Kertesz NJ, Pediatric nonpost-operative junctional ectopic tachycardia medical management and interventional therapies. J Am Coll Cardiol 2009 53 690 7
307. Batra AS, Chun DS, Johnson TR, A prospective analysis of the incidence and risk factors associated with junctional ectopic tachycardia following surgery for congenital heart disease. Pediatr Cardiol 2006 27 51 5
308. Andreasen JB, Johnsen SP, Ravn HB, Junctional ectopic tachycardia after surgery for congenital heart disease in children. Intensive Care Med 2008 34 895 902
309. Haas NA, Camphausen CK, Impact of early and standardized treatment with amiodarone on therapeutic success and outcome in pediatric patients with postoperative tachyarrhythmia. J Thorac Cardiovasc Surg 2008 136 1215 22
310. Laird WP, Snyder CS, Kertesz NJ, Use of intravenous amiodarone for postoperative junctional ectopic tachycardia in children. Pediatr Cardiol 2003 24 133 7
311. Kovacikova L, Hakacova N, Dobos D, Amiodarone as a first-line therapy for postoperative junctional ectopic tachycardia. Ann Thorac Surg 2009 88 616 22
312. Walsh EP, Saul JP, Sholler GF, Evaluation of a staged treatment protocol for rapid automatic junctional tachycardia after operation for congenital heart disease. J Am Coll Cardiol 1997 29 1046 53
313. Sanatani S, Potts JE, Reed JH, The study of antiarrhythmic medications in infancy (SAMIS): a multicenter, randomized controlled trial comparing the efficacy and safety of digoxin versus propranolol for prophylaxis of supraventricular tachycardia in infants. Circ Arrhythm Electrophysiol 2012 5 984 91
314. van Engelen AD, Weijtens O, Brenner JI, Management outcome and follow-up of fetal tachycardia. J Am Coll Cardiol 1994 24 1371 5
315. Bouchardy J, Therrien J, Pilote L, Atrial arrhythmias in adults with congenital heart disease. Circulation 2009 120 1679 86
316. Bernier M, Marelli AJ, Pilote L, Atrial arrhythmias in adult patients with right- versus left-sided congenital heart disease anomalies. Am J Cardiol 2010 106 547 51
317. Engelfriet P, Boersma E, Oechslin E, The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease. Eur Heart J 2005 26 2325 33
318. Trojnarska O, Grajek S, Kramer L, Risk factors of supraventricular arrhythmia in adults with congenital heart disease. Cardiol J 2009 16 218 26
319. Verheugt CL, Uiterwaal CSPM, van der Velde ET, Gender and outcome in adult congenital heart disease. Circulation 2008 118 26 32
320. Akar JG, Kok LC, Haines DE, Coexistence of type I atrial flutter and intra-atrial re-entrant tachycardia in patients with surgically corrected congenital heart disease. J Am Coll Cardiol 2001 38 377 84
321. Collins KK, Love BA, Walsh EP, Location of acutely successful radiofrequency catheter ablation of intraatrial reentrant tachycardia in patients with congenital heart disease. Am J Cardiol 2000 86 969 74
322. de Groot NMS, Zeppenfeld K, Wijffels MC, Ablation of focal atrial arrhythmia in patients with congenital heart defects after surgery: role of circumscribed areas with heterogeneous conduction. Heart Rhythm 2006 3 526 35
323. Koyak Z, Kroon B, de Groot JR, Efficacy of antiarrhythmic drugs in adults with congenital heart disease and supraventricular tachycardias. Am J Cardiol 2013 112 1461 7
324. Mah DY, Alexander ME, Cecchin F, The electroanatomic mechanisms of atrial tachycardia in patients with tetralogy of Fallot and double outlet right ventricle. J Cardiovasc Electrophysiol 2011 22 1013 7
325. Wasmer K, Köbe J, Dechering DG, Isthmus-dependent right atrial flutter as the leading cause of atrial tachycardias after surgical atrial septal defect repair. Int J Cardiol 2013 168 2447 52
326. de Groot NMS, Atary JZ, Blom NA, Long-term outcome after ablative therapy of postoperative atrial tachyarrhythmia in patients with congenital heart disease and characteristics of atrial tachyarrhythmia recurrences. Circ Arrhythm Electrophysiol 2010 3 148 54
327. Hårdhammar PA, van Beusekom HM, Emanuelsson HU, Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries. Circulation 1996 93 423 30
328. Tanner H, Lukac P, Schwick N, Irrigated-tip catheter ablation of intraatrial reentrant tachycardia in patients late after surgery of congenital heart disease. Heart Rhythm 2004 1 268 75
329. Triedman JK, Saul JP, Weindling SN, Radiofrequency ablation of intra-atrial reentrant tachycardia after surgical palliation of congenital heart disease. Circulation 1995 91 707 14
330. DeMazumder D, Lake DE, Cheng A, Dynamic analysis of cardiac rhythms for discriminating atrial fibrillation from lethal ventricular arrhythmias. Circ Arrhythm Electrophysiol 2013 6 555 61
331. Yap S-C, Harris L, Silversides CK, Outcome of intra-atrial re-entrant tachycardia catheter ablation in adults with congenital heart disease: negative impact of age and complex atrial surgery. J Am Coll Cardiol 2010 56 1589 96
332. Ammash NM, Phillips SD, Hodge DO, Outcome of direct current cardioversion for atrial arrhythmias in adults with congenital heart disease. Int J Cardiol 2012 154 270 4
333. Pass RH, Liberman L, Al-Fayaddh M, Continuous intravenous diltiazem infusion for short-term ventricular rate control in children. Am J Cardiol 2000 86 559 62, A9
334. Garnock-Jones KP, Esmolol: a review of its use in the short-term treatment of tachyarrhythmias and the short-term control of tachycardia and hypertension. Drugs 2012 72 109 32
335. diMarco JP, Sellers TD, Lerman BB, Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias. J Am Coll Cardiol 1985 6 417 25
336. Haines DE, DiMarco JP, Sustained intraatrial reentrant tachycardia: clinical, electrocardiographic and electrophysiologic characteristics and long-term follow-up. J Am Coll Cardiol 1990 15 1345 54
337. Kall JG, Kopp D, Olshansky B, Adenosine-sensitive atrial tachycardia. Pacing Clin Electrophysiol 1995 18 300 6
338. Olshansky B, Okumura K, Hess PG, Use of procainamide with rapid atrial pacing for successful conversion of atrial flutter to sinus rhythm. J Am Coll Cardiol 1988 11 359 64
339. Heisel A, Jung J, Stopp M, Facilitating influence of procainamide on conversion of atrial flutter by rapid atrial pacing. Eur Heart J 1997 18 866 9
340. Hoyer AW, Balaji S, The safety and efficacy of ibutilide in children and in patients with congenital heart disease. Pacing Clin Electrophysiol 2007 30 1003 8
341. Crawford W, Plumb VJ, Epstein AE, Prospective evaluation of transesophageal pacing for the interruption of atrial flutter. Am J Med 1989 86 663 7
342. Rhodes LA, Walsh EP, Saul JP, Conversion of atrial flutter in pediatric patients by transesophageal atrial pacing: a safe, effective, minimally invasive procedure. Am Heart J 1995 130 323 7
343. Brockmeier K, Ulmer HE, Hessling G, Termination of atrial reentrant tachycardias by using transesophageal atrial pacing. J Electrocardiol 2002 35 Suppl 159 63
344. Stephenson EA, Casavant D, Tuzi J, Efficacy of atrial antitachycardia pacing using the Medtronic AT500 pacemaker in patients with congenital heart disease. Am J Cardiol 2003 92 871 6
345. Rao SO, Boramanand NK, Burton DA, Atrial tachycardias in young adults and adolescents with congenital heart disease: conversion using single dose oral sotalol. Int J Cardiol 2009 136 253 7
346. Wells R, Khairy P, Harris L, Dofetilide for atrial arrhythmias in congenital heart disease: a multicenter study. Pacing Clin Electrophysiol 2009 32 1313 8
347. Warnes CA, Williams RG, Bashore TM, ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008 118 e714 833
348. Khairy P, Van Hare GF, Balaji S, PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm 2014 11 e102 65
349. Huang CJ, Chiu IS, Lin FY, Role of electrophysiological studies and arrhythmia intervention in repairing Ebstein's anomaly. Thorac Cardiovasc Surg 2000 48 347 50
350. Reich JD, Auld D, Hulse E, The Pediatric Radiofrequency Ablation Registry's experience with Ebstein's anomaly. Pediatric Electrophysiology Society. J Cardiovasc Electrophysiol 1998 9 1370 7
351. Cappato R, Schlüter M, Weiss C, Radiofrequency current catheter ablation of accessory atrioventricular pathways in Ebstein's anomaly. Circulation 1996 94 376 83
352. Misaki T, Watanabe G, Iwa T, Surgical treatment of patients with Wolff-Parkinson-White syndrome and associated Ebstein's anomaly. J Thorac Cardiovasc Surg 1995 110 1702 7
353. Khositseth A, Danielson GK, Dearani JA, Supraventricular tachyarrhythmias in Ebstein anomaly: management and outcome. J Thorac Cardiovasc Surg 2004 128 826 33
354. Bockeria L, Golukhova E, Dadasheva M, Advantages and disadvantages of one-stage and two-stage surgery for arrhythmias and Ebstein's anomaly. Eur J Cardiothorac Surg 2005 28 536 40
355. Pressley JC, Wharton JM, Tang AS, Effect of Ebstein's anomaly on short- and long-term outcome of surgically treated patients with Wolff-Parkinson-White syndrome. Circulation 1992 86 1147 55
356. Khairy P, Harris L, Landzberg MJ, Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study. Circ Arrhythm Electrophysiol 2008 1 250 7
357. Lukac P, Pedersen AK, Mortensen PT, Ablation of atrial tachycardia after surgery for congenital and acquired heart disease using an electroanatomic mapping system: which circuits to expect in which substrate? Heart Rhythm 2005 2 64 72
358. Yap S-C, Harris L, Downar E, Evolving electroanatomic substrate and intra-atrial reentrant tachycardia late after Fontan surgery. J Cardiovasc Electrophysiol 2012 23 339 45
359. Wu J, Deisenhofer I, Ammar S, Acute and long-term outcome after catheter ablation of supraventricular tachycardia in patients after the Mustard or Senning operation for D-transposition of the great arteries. Europace 2013 15 886 91
360. Jones DG, Jarman JWE, Lyne JC, The safety and efficacy of trans-baffle puncture to enable catheter ablation of atrial tachycardias following the Mustard procedure: a single centre experience and literature review. Int J Cardiol 2013 168 1115 20
361. Scaglione M, Caponi D, Ebrille E, Very long-term results of electroanatomic-guided radiofrequency ablation of atrial arrhythmias in patients with surgically corrected atrial septal defect. Europace 2014 1800 7
362. Giamberti A, Chessa M, Abella R, Surgical treatment of arrhythmias in adults with congenital heart defects. Int J Cardiol 2008 129 37 41
363. Stulak JM, Dearani JA, Puga FJ, Right-sided Maze procedure for atrial tachyarrhythmias in congenital heart disease. Ann Thorac Surg 2006 81 1780 4
364. Mavroudis C, Deal BJ, Backer CL, Arrhythmia surgery in patients with and without congenital heart disease. Ann Thorac Surg 2008 86 857 68
365. Karamlou T, Silber I, Lao R, Outcomes after late reoperation in patients with repaired tetralogy of Fallot: the impact of arrhythmia and arrhythmia surgery. Ann Thorac Surg 2006 81 1786 93
366. Deal BJ, Mavroudis C, Backer CL, Comparison of anatomic isthmus block with the modified right atrial maze procedure for late atrial tachycardia in Fontan patients. Circulation 2002 106 575 9
367. Mavroudis C, Backer CL, Deal BJ, Total cavopulmonary conversion and maze procedure for patients with failure of the Fontan operation. J Thorac Cardiovasc Surg 2001 122 863 71
368. Mavroudis C, Deal BJ, Backer CL, J. Maxwell Chamberlain Memorial Paper for congenital heart surgery. 111 Fontan conversions with arrhythmia surgery: surgical lessons and outcomes. Ann Thorac Surg 2007 84 1457 65
369. Aboulhosn J, Williams R, Shivkumar K, Arrhythmia recurrence in adult patients with single ventricle physiology following surgical Fontan conversion. Congenit Heart Dis 2010 5 430 4
370. Said SM, Burkhart HM, Schaff HV, Fontan conversion: identifying the high-risk patient. Ann Thorac Surg 2014 97 2115 21
371. Gutierrez SD, Earing MG, Singh AK, Atrial tachyarrhythmias and the Cox-maze procedure in congenital heart disease. Congenit Heart Dis 2013 8 434 9
372. Terada T, Sakurai H, Nonaka T, Surgical outcome of Fontan conversion and arrhythmia surgery: Need a pacemaker? Asian Cardiovasc Thorac Ann 2013 22 682 6
373. Theodoro DA, Danielson GK, Porter CJ, Right-sided maze procedure for right atrial arrhythmias in congenital heart disease. Ann Thorac Surg 1998 65 149 53
374. Silka MJ, Manwill JR, Kron J, Bradycardia-mediated tachyarrhythmias in congenital heart disease and responses to chronic pacing at physiologic rates. Am J Cardiol 1990 65 488 93
375. Ragonese P, Drago F, Guccione P, Permanent overdrive atrial pacing in the chronic management of recurrent postoperative atrial reentrant tachycardia in patients with complex congenital heart disease. Pacing Clin Electrophysiol 1997 20 2917 23
376. Banchs JE, Baquero GA, Nickolaus MJ, Clinical efficacy of dofetilide for the treatment of atrial tachyarrhythmias in adults with congenital heart disease. Congenit Heart Dis 2014 9 221 7
377. Tanel RE, Walsh EP, Lulu JA, Sotalol for refractory arrhythmias in pediatric and young adult patients: initial efficacy and long-term outcome. Am Heart J 1995 130 791 7
378. Shotan A, Ostrzega E, Mehra A, Incidence of arrhythmias in normal pregnancy and relation to palpitations, dizziness, and syncope. Am J Cardiol 1997 79 1061 4
379. Tawam M, Levine J, Mendelson M, Effect of pregnancy on paroxysmal supraventricular tachycardia. Am J Cardiol 1993 72 838 40
380. Ghosh N, Luk A, Derzko C, The acute treatment of maternal supraventricular tachycardias during pregnancy: a review of the literature. J Obstet Gynaecol Can 2011 33 17 23
381. Allen NM, Page RL, Procainamide administration during pregnancy. Clin Pharm 1993 12 58 60
382. Qasqas SA, McPherson C, Frishman WH, Cardiovascular pharmacotherapeutic considerations during pregnancy and lactation. Cardiol Rev 2004 12 201 21
383. Bartalena L, Bogazzi F, Braverman LE, Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment. J Endocrinol Invest 2001 24 116 30
384. Jaeggi ET, Carvalho JS, De Groot E, Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study. Circulation 2011 124 1747 54
385. Ersbøll AS, Hedegaard M, Søndergaard L, Treatment with oral beta-blockers during pregnancy complicated by maternal heart disease increases the risk of fetal growth restriction. BJOG 2014 121 618 26
386. Szumowski L, Szufladowicz E, Orczykowski M, Ablation of severe drug-resistant tachyarrhythmia during pregnancy. J Cardiovasc Electrophysiol 2010 21 877 82
387. Damilakis J, Theocharopoulos N, Perisinakis K, Conceptus radiation dose and risk from cardiac catheter ablation procedures. Circulation 2001 104 893 7
388. Chen SA, Lee SH, Wu TJ, Initial onset of accessory pathway-mediated and atrioventricular node reentrant tachycardia after age 65: clinical features, electrophysiologic characteristics, and possible facilitating factors. J Am Geriatr Soc 1995 43 1370 7
389. Chen SA, Chiang CE, Tai CT, Complications of diagnostic electrophysiologic studies and radiofrequency catheter ablation in patients with tachyarrhythmias: an eight-year survey of 3,966 consecutive procedures in a tertiary referral center. Am J Cardiol 1996 77 41 6
390. Zado ES, Callans DJ, Gottlieb CD, Efficacy and safety of catheter ablation in octogenarians. J Am Coll Cardiol 2000 35 458 62
391. Rostock T, Risius T, Ventura R, Efficacy and safety of radiofrequency catheter ablation of atrioventricular nodal reentrant tachycardia in the elderly. J Cardiovasc Electrophysiol 2005 16 608 10
392. Kihel J, Da Costa A, Kihel A, Long-term efficacy and safety of radiofrequency ablation in elderly patients with atrioventricular nodal re-entrant tachycardia. Europace 2006 8 416 20
393. Dagres N, Piorkowski C, Kottkamp H, Contemporary catheter ablation of arrhythmias in geriatric patients: patient characteristics, distribution of arrhythmias, and outcome. Europace 2007 9 477 80
394. Pedrinazzi C, Durin O, Agricola P, Efficacy and safety of radiofrequency catheter ablation in the elderly. J Interv Card Electrophysiol 2007 19 179 85
395. Hoffmann BA, Brachmann J, Andresen D, Ablation of atrioventricular nodal reentrant tachycardia in the elderly: results from the German Ablation Registry. Heart Rhythm 2011 8 981 7
396. Yangni NO, Brembilla-Perrot B, Clinical characteristics and management of paroxysmal junctional tachycardia in the elderly. Arch Cardiovasc Dis 2008 101 143 8
397. Dewland TA, Glidden DV, Marcus GM, Healthcare utilization and clinical outcomes after catheter ablation of atrial flutter. PLoS One 2014 9 e100509